Edition:
United Kingdom

Amneal Pharmaceuticals Inc (AMRX.N)

AMRX.N on New York Stock Exchange

16.89USD
10 Dec 2018
Change (% chg)

$-0.46 (-2.65%)
Prev Close
$17.35
Open
$17.27
Day's High
$17.46
Day's Low
$16.30
Volume
186,987
Avg. Vol
282,642
52-wk High
$24.45
52-wk Low
$13.50

Chart for

About

Amneal Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company is engaged in the development, manufacture and marketing of bioequivalent pharmaceutical products (generics), in addition to the development and marketing of branded products. It operates in two segments, which include Impax Generics and Impax... (more)

Overall

Beta: 1.03
Market Cap(Mil.): $1,620.01
Shares Outstanding(Mil.): 74.31
Dividend: --
Yield (%): --

Financials

  AMRX.N Industry Sector
P/E (TTM): -- 31.13 33.63
EPS (TTM): -8.08 -- --
ROI: -39.49 15.55 15.02
ROE: -72.27 16.92 16.60

U.S. mergers help bank fees spike to record highs

NEW YORK (LPC) - A record $1.45 trillion of US syndicated lending to companies for acquisitions, leveraged buyouts, dividends and refinancing in the first half of the year has propelled bank fees from arranging the loans to all-time highs.

09 Jul 2018

US mergers help bank fees spike to record highs

NEW YORK, July 9 (LPC) - A record US$1.45trn of US syndicated lending to companies for acquisitions, leveraged buyouts, dividends and refinancing in the first half of the year has propelled bank fees from arranging the loans to all-time highs.

09 Jul 2018

Earnings vs. Estimates